Net Cash Provided by (Used in) Operating Activities |
-428K |
USD |
+61.5% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
234K |
USD |
|
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
280K |
USD |
|
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
1B |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
109M |
shares |
+3.71% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
85.4K |
USD |
|
Q1 2025 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
23.9K |
USD |
-73.4% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
7.71M |
USD |
+11% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
8.88M |
USD |
-0.85% |
Q4 2024 |
FY 2024 |
Depreciation |
717K |
USD |
-69.6% |
Q2 2025 |
Q2 2025 |
Payments to Acquire Property, Plant, and Equipment |
746K |
USD |
|
Q1 2023 |
Q1 2023 |
Property, Plant and Equipment, Gross |
7.42M |
USD |
|
Q2 2023 |
Q2 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
5.36M |
USD |
+13.6% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
1.17M |
USD |
-41.8% |
Q4 2024 |
FY 2024 |
Share-based Payment Arrangement, Expense |
164K |
USD |
+216% |
Q2 2025 |
Q2 2025 |
Interest Expense |
455K |
USD |
-38.4% |
Q2 2025 |
Q2 2025 |